Annapolis News Updates

Grand View Research, Inc. – Market Research And Consulting

According to a report, “Regenerative Medicine Market Analysis By Product (Therapeutics {Primary Cell-based, Stem Cell-based, Immunotherapies, & Gene Therapies}, Tools, Banks, & Services), By Therapeutic Category, And Segment Forecasts, 2018 – 2025” , published by Grand View Research, Inc.,  The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, This enriched knowledge, coupled with emergence of novel streams of biotechnology such as gene therapy and nanotechnology, further prospered use of cell-based technology in therapeutic treatment. Well established regenerative approached for various dermatological indications exists since ages. Technological advances introduced scaffolds, matrices, and grafts engineered for faster regeneration and minimal surgical procedure.

Identification of ability of stem cells to develop into various different cell lines further propelled the advancements in regenerative medicine. Frequent media exposure due to regulatory as well as ethical controversies around embryonic stem cells has increased awareness among the masses. This encouraged researchers to explore and develop other potential fields for similar applications, such as induced pluripotent stem cells (iPSC).

Furthermore, the emergence of gene therapy techniques with potential to rectify and restore effects of gene mutations in cells is under development. Conditions caused due to Single Nucleotide Polymorphism (SNP) as well as mutations that induce degenerative characteristics are primarily targeted.

Key Takeaways from the report:

• The global regenerative medicine demand exceeded USD 1.7 billion in 2016 and is expected to grow at a considerable rate over the forecast period owing to the presence of a strong looking product pipeline with anticipated commercializations just around the corner

• Therapeutics emerged as the largest product segment in 2016 as it has a relatively high implementation and usage rate resulting in higher adoption

• Global regenerative services demand for facilities such as tissue banks and cellular engineering tools is expected to drive demand in the segment

• The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies with increased focus of dominant players in emerging economies is attributive to market growth. market.

• Key players including Asterias Bio, Athersys, Integra LifeSciences Corpotation, and MiMedx are involved in complex technical cum financial partnerships with larger players in an attempt to expedite R&D

Biologics, individually or in combination with cells or devices, are explored to support regenerate the biological functions of cells, tissues, or organs. A number of combinatorial therapies to support chemotherapy and other cancer treatments by prevention as well as treatment for cancer relapse are in development phases.

In addition, rising prevalence of complicated degenerative disorders such as age-related macular degeneration, Alzheimer’s disease, and Parkinson’s disease, especially in the aging population resulted in high investments in R&D to develop therapeutic solutions.

UK regenerative medicine market revenue by product type, 2014 – 2025 (USD Million)

Browse More Reports in Biotechnology Industry:

Carcinoembryonic Antigen (CEA) Market: Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. 

Bioinformatics Market:  Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years. Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market.

Global regenerative market revenue by therapeutic category, 2016 (%)

Regenerative medicine grabs the attention of the healthcare industry owing to its promising applications along with significant advances in supportive fields including tissue engineering, stem cells, gene therapy, drug discovery and nanotechnology. For instance, 3D printing over scaffold with stem cells to restore structure as well as functional characteristics of biological cells, tissues, and organs.

Grand View Research has segmented the global regenerative medicine market on the basis of product, therapeutic category, and region:

Regenerative Medicine Product Outlook (Revenue, USD Million, 2014 – 2025)

• Therapeutics & Devices

  • Primary Cell-bases therapeutics 

    • Dermatology

    • Musculoskeletal

    • Surgical

    • Dental

    • Others

  • Stem Cell & Progenitor Cell-based therapeutics

    • Autologous

    • Allogeneic

    • Others

  • Tools

  • Banks

  • Services

Regenerative Medicine Therapeutic Category Outlook (Revenue, USD Million, 2014 – 2025)

• Dermatology

• Musculoskeletal

• Immunology & Inflammation

• Oncology

• Cardiovascular

• Ophthalmology

• Others

Regenerative Medicine Regional Outlook (Revenue, USD Million, 2014 – 2025)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

• Asia Pacific

  • China

  • Japan

• Latin America

  • Brazil

• Middle East & Africa

  • South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information: www.grandviewresearch.com

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: Switzerland
Website: www.grandviewresearch.com/industry-analysis/regenerative-medicine-market